Pharmaceuticals Projects in India – Page 8

1,542 upcoming and ongoing pharmaceuticals projects in India worth ₹665,172 Cr, with investment, location, project stage and latest status. Last updated 08 Oct 2026.

Projects tracked
1,542
Total investment
₹665,172 Cr
Pre-project / Under construction
0 / 0
Added in the last 30 days
14

Latest pharmaceuticals projects in India

Showing 36–40 of 1,542
  1. Pre Project Stage Pharmaceuticals Projects Updated

    Rs.1507 Million Bulk Drugs Expansion Project in Bidar District, Karnataka

    Karnataka From 1000 Million to 4999 Million

    A pharmaceutical manufacturing unit at Humnabad, Bidar, Karnataka is proposing a change in product mix, discontinuing 18 existing products while retaining 4 with revised capacities and adding 32 new products including custom synthesis products. The ₹150.70 crore project involves an additional 1.17 hectares of non-forest land alongside the existing 3.63 hectares, raising total permanent operational employment from 130 to 205. The proposal is currently under verification with the Ministry of Environment, Forest and Climate Change for environmental clearance.

    View project
  2. Environment Clearance Stage Pharmaceuticals Projects Updated

    Rs.163 Million Pharmaceutical Formulation Manufacturing Project in Thane, Maharashtra

    Maharashtra From 100 Million to 999 Million

    A pharmaceutical formulation manufacturing facility with a capacity of 10 lakh units per year is coming up in the TTC Industrial Area, MIDC Khairane, Navi Mumbai. The project also includes research and development activity for active pharmaceutical ingredients on a non-commercial basis. The State Pollution Control Board has granted Consent to Establish for the project under the Orange Category.

    View project
  3. Pre Project Stage Pharmaceuticals Projects Updated

    Rs.15000 Million New Monoclonal Antibodies Mfg. Unit in Sangareddy district, Telangana

    Telangana From 5000 Million to 49999 Million

    A new biologics manufacturing complex is planned across a 10-hectare site in Kandi Mandal, Sangareddy, with total built-up area of over 55,747 sqm dedicated to R&D and manufacturing of monoclonal antibodies (mAbs). The proposal, categorized under B2 EIA norms, is currently under verification with the Ministry of Environment, Forest and Climate Change ahead of Environmental Clearance.

    View project
  4. Pre Project Stage Pharmaceuticals Projects Updated

    Rs.121 Million Active Pharmaceutical Ingredients and Intermediates Mfg. Unit in Ranipet, Tamil Nadu

    Tamil Nadu From 100 Million to 999 Million

    A new Active Pharmaceutical Ingredients (API) and intermediates manufacturing facility with a combined capacity of 9.2 TPA is proposed at Plot No. A11, SIPCOT Industrial Park - Multisector SEZ, Mukundarayapuram Village, Ranipet District, Tamil Nadu. The proposal is currently under examination for Terms of Reference by the Ministry of Environment, Forest and Climate Change, with physical construction yet to begin. The unit is designed to manufacture specialty pharmaceutical intermediates such as Pentosan Polysulphate Sodium, Calcium Folinate, Sodium Levo Folinate and 5-Fluoro Uracil.

    View project
  5. Pre Project Stage Pharmaceuticals Projects Updated

    API, Intermediates & Fine Chemicals Manufacturing Expansion Project in Raigad, Maharashtra

    Maharashtra Less than 100 Million

    An existing active pharmaceutical ingredients (API), intermediates and fine chemicals manufacturing unit at MIDC Taloja, Raigad is seeking fresh Terms of Reference for a change in product mix within its existing plant, with total capacity remaining at 73.5 TPA. No additional land, building or machinery investment is involved, as the plant has been operational since 1986 under a valid Consent to Operate. The proposal is currently under environmental review with a clarification query raised by the appraisal committee.

    View project